Zur Kurzanzeige

dc.contributor.authorSerramito-Gómez, Inmaculada
dc.contributor.authorM Clarke, Kathyrn
dc.contributor.authorRodríguez Vicente, Ana E. 
dc.contributor.authorE McGimpsey, Julie
dc.contributor.authorAbáigar Alvarado, María
dc.contributor.authorBarranquero Díez, Carlos
dc.contributor.authorBenito Sánchez, Rocío 
dc.contributor.authorBullinger, Lars
dc.contributor.authorI Mills, Ken
dc.contributor.authorHernández Rivas, Jesús María 
dc.contributor.authorClarke, Kathryn M
dc.contributor.authorRodríguez-Vicente, Ana Eugenia
dc.contributor.authorMcGimpsey, Julie E
dc.contributor.authorDíez, Carlos Barranquero
dc.contributor.authorMills, Ken I
dc.date.accessioned2026-05-07T15:18:26Z
dc.date.available2026-05-07T15:18:26Z
dc.date.issued2021-02
dc.identifier.citationSerramito-Gómez, I., Clarke, K. M., Rodríguez-Vicente, A. E., McGimpsey, J. E., Abáigar, M., Díez, C. B., ... & Rivas, J. M. H. (2021). NEMHESYS—European perspective on the implementation of next-generation sequencing into clinical diagnostics. HemaSphere, 5(3), e541.es_ES
dc.identifier.issn0037-9727
dc.identifier.urihttp://hdl.handle.net/10366/171301
dc.description.abstract[EN]NGS Establishment in Multidisciplinary Healthcare (NEMHESYS) is an Erasmus+ programme with the purpose of providing qualified staff with the essential technical and bioinformatic knowledge and skills on next-generation sequencing (NGS) to be able to carry out NGS studies and perform some of the most common types of analyses. The clinical application of NGS has become easier with advancements in technologies. However, the investment needed to bring NGS into medical practice remains significant, with the scale of knowledge required being unprecedented at most hospitals. In addition, these novel technologies bring new challenges in translating NGS to clinical practice, at both technical and regulatory level, in terms of data management, interpretation of the results, and genetic counseling. All these aspects justify the consideration of what will be the precise role of NGS in diagnosis, risk assessment, response prediction, and treatment monitoring, today and tomorrow. Thus, to evaluate the implementation of NGS in European healthcare/research centers, a mapping survey was carried out, based on previous NGS mapping studies.es_ES
dc.format.mimetypeapplication/pdf
dc.language.isoenges_ES
dc.relation.ispartofseries21GMO;2
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationales_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/es_ES
dc.subjectNGSes_ES
dc.subjectClinical Diagnosticses_ES
dc.titleNEMHESYS-European perspective on the implementation of next-generation sequencing into clinical diagnosticses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/ 10.1097/HS9.0000000000000541es_ES
dc.identifier.doi10.1097/HS9.0000000000000541
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.pmid33623883
dc.identifier.essn2572-9241
dc.journal.titleHemaspherees_ES
dc.volume.number17es_ES
dc.issue.number5es_ES
dc.page.initial541es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decsdiagnóstico clínico *


Dateien zu dieser Ressource

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige

Attribution-NonCommercial-NoDerivatives 4.0 International
Solange nicht anders angezeigt, wird die Lizenz wie folgt beschrieben: Attribution-NonCommercial-NoDerivatives 4.0 International